Capital Financial Planning »

Regeneron Pharmaceuticals shares owned by Capital Financial Planning

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Capital Financial Planning from 13F filings

Historical chart of Capital Financial Planning investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Capital Financial Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Capital Financial Planning

Quarter filed Position value Share count Share price at filing
2023-09-30 $216k 263 822.96
2023-06-30 $216k 301 718.54
2023-03-31 $244k 297 821.67
2022-12-31 $214k 297 721.49
2022-03-31 $219k 313 699.68
2021-12-31 $217k 344 630.81
2021-09-30 $204k 337 605.34
2020-06-30 $206k 330 624.24
2018-12-31 $33k 90 363.64

More positions owned by Capital Financial Planning

Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Apple (AAPL)
Ishares Tr Rusel 2500 Etf (SMMD)
Select Sector Spdr Tr Technology (XLK)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Ishares Tr Core High Dv Etf (HDV)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Core Div Grwth (DGRO)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Pimco Etf Tr Inv Grd Crp Bd (CORP)
Vanguard Index Fds Small Cp Etf (VB)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr Sbi Healthcare (XLV)

View all positions for Capital Financial Planning

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals